- Report
- January 2024
- 150 Pages
Global
From €4557EUR$4,850USD£3,801GBP
- Report
- May 2026
- 64 Pages
Canada
From €4693EUR$4,995USD£3,914GBP
- Report
- May 2026
- 59 Pages
Germany
From €4693EUR$4,995USD£3,914GBP
- Report
- May 2026
- 61 Pages
India
From €4693EUR$4,995USD£3,914GBP
- Report
- May 2026
- 63 Pages
Australia
From €4693EUR$4,995USD£3,914GBP
- Report
- May 2026
- 103 Pages
Russia, India, China, ... Russia, India, China, Brazil
From €5632EUR$5,995USD£4,698GBP
- Report
- December 2024
- 436 Pages
Global
From €3758EUR$4,000USD£3,135GBP
- Report
- August 2024
- 189 Pages
Global
From €3758EUR$4,000USD£3,135GBP
- Report
- February 2024
- 48 Pages
Global
From €2349EUR$2,500USD£1,959GBP
- Report
- October 2024
- 70 Pages
North America
From €893EUR$950USD£744GBP
- Report
- October 2024
- 70 Pages
Asia Pacific
From €893EUR$950USD£744GBP
- Report
- October 2024
- 70 Pages
Latin America
From €893EUR$950USD£744GBP
- Report
- October 2024
- 70 Pages
China
From €893EUR$950USD£744GBP
- Report
- October 2024
- 70 Pages
France
From €893EUR$950USD£744GBP
- Report
- October 2024
- 70 Pages
Germany
From €893EUR$950USD£744GBP
- Report
- October 2024
- 70 Pages
India
From €893EUR$950USD£744GBP
- Report
- October 2024
- 70 Pages
United Kingdom
From €893EUR$950USD£744GBP
- Report
- October 2024
- 70 Pages
United States
From €893EUR$950USD£744GBP
- Report
- October 2024
- 70 Pages
China
From €893EUR$950USD£744GBP
- Report
- October 2024
- 70 Pages
France
From €893EUR$950USD£744GBP

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more